Why Menopause Affects Your Heart, Bones, and Brain — Not Just Your Hormones
Talk to anyone about the effects that menopause has on the body and they will tell you that their lives will be characterized by hot flushes, unstable cycles, and instability in their mood. It is not that those answers are wrong. However, they are not complete and there is a lot of discrepancy between what is familiar and what is being done.
Menopause is not merely a hormonal process that is acted out over a span of a few years and vanishes. It is a biological change that redevelops the functioning of multiple key body systems, such as the heart, the skeleton, and the brain. The consequences of that remaking may derive years or decades beyond evaporation of the final hot rush.
Published in late 2024 by Jean Hailes high-end womens health organization, a study had discovered that women generally knew the immediate impact of menopause, but only very few of them had any idea regarding the long-term health outcome. Nobody emphasized osteoporosis spontaneously. They did not even have cardiovascular disease and cognitive changes on their radar. That knowledge gap is a worthwhile thing to fill in to have a transition that would touch all women as long as they live long enough to witness the transition.
This article describes individually the three largest long-term systems that are influenced by menopause that include the heart, the bones, and the brain, and how it actually works, why it works and what the evidence itself indicates.
To know why menopause is having such an impact on such a wide number of body systems you must first learn to appreciate how far-reaching oestrogen receptors are in the body. Oestrogen is not simply a “female reproductive hormone.” It is a signalling molecule that has receptors in the heart, blood vessels, bone cells, brain neurons, liver, skin, bladder and so on.
Once the oestrogen reduces, as it does during the menopause transition, every such receptor in the body receives decreased signal which it has been responding to over many decades. The effects of such withdrawal are not restricted to the reproductive system. They spread out, and this occurrence can be measured, clinically significant, and at times irreversible without this action being taken in the early stages.
This is the reason why menopause is not all a women health narrative. It is a health tale of a whole body.
The first cause of women death in Australia is heart disease. This fact alone will put the discussion of the connection between menopause and cardiovascular health in a different perspective, though this is one of the least recognized aspects of the transition.
At premenopausal age, women are usually considered to be at a low risk of cardiovascular disease compared to men of the same age. Oestrogen seems to work in this relative protection in a number of ways: it helps keep blood vessel walls flexible and responsive, it helps give the blood vessels better cholesterol profiles with LDL (the bad cholesterol) kept lower and HDL (the good cholesterol) kept higher, and it has anti-inflammatory and antioxidant effects that keep the arteries in good health.
During and after menopause, these protective mechanisms are weakened by a decrease in the level of oestrogen. The outcome in the postmenopausal years is an increase in cardiovascular risk profile, which ultimately approaches the level of risk in men.
The cardiovascular menopause alterations are not abstract and hypothetical. They are quantifiable and recorded:
This is one of the recent discoveries of a research study that shocked most clinicians that is the connection between vasomotor symptoms, especially hot flushes that are frequent and severe as well as night sweats, and cardiovascular risk. Hot flushes that are frequent and severe also seem to put women at a greater risk of cardiovascular events than women who have mild or no vasomotor symptoms.
The mechanism is not completely clear. Hot flushes can also be the evidence of the extent of the vasoconstriction that takes place in the process of transition, and they may not be the causes. However, this connection is uniform enough in various studies so that common vasomotor symptoms are finally being viewed by some cardiologists as one of the women-specific cardiovascular risk factors that can be discussed together with the established ones.
A significant lesson learnt about cardiovascular research of menopause is that the age of menopause seems to have an extensive influence on later cardiovascular well-being. A study published in Best Practice and research Clinical Obstetrics and Gynaecology has established that an earlier age of menopause is systematically related to a greater risk of cardiovascular disease in later life and that women who enter menopause at an age below 45 are consistently at a more significant risk of acquiring cardiovascular disease in later life than women who enter menopause at the average age.
The duration of oestrogen deprivation is the higher the cumulative effects of the risk factors mentioned above of the cardiovascular system. It is one of the major reasons why premature and early menopause involve particular health consequences in the long run, which need special medical consideration.
Beginning approximately in the period of menopause, cardiovascular health surveillance takes on real significance. Australian recommendations propose regular heart health check-up by all women above the age of 45 that will involve blood pressure measurement, cholesterol test, and other risk factors. In the case of Aboriginal and Torres Strait Islander women, it is advised between the ages of 30 to 35 due to increased baseline cardiovascular risk.
The lifestyle interventions that promote cardiovascular health: exercises, not smoking, low saturated fat diet rich in vegetables and wholegrains, weight control and blood pressure are weight bearing during and after menopause transition.
Osteoporosis is regarded as an old age disease and as such, what takes place to old ladies who keep on fracturing their hips in their 80s. What is lacking to that framing, albeit not wholly false, is the fact that it does not consider that bone loss that results in osteoporosis; the bone loss that starts in the menopause transition itself, which can be many decades or two before a fracture has ever been detected.
Oestrogen plays an important role in controlling bone remodelling. In the course of adult life, bone is persistently broken down by osteoclast cells and rebuilt by the osteoblast cells. The contentious role of oestrogen is to maintain this balance by inhibiting osteoclasts activity or in other words decreasing the speed at which the bone is taken away. Live depletion of oestrogen decelerates the brakes of osteoclast action, and bone is decalcified before replacement can take place.
The loss rate of bone is not uniform throughout the menopause transition. According to a study titled Study of Women’s Health Across the Nation (SWAN) which was one of the most extensive longitudinal studies on menopause transition ever to have been carried out, bone loss increases significantly during late perimenopausal phase and this increases start at about one to two years before the final menstrual period and the process continues over the next few years during the early postmenopausal years at a similar rate.
It is worth stopping here. This is because the most rapid step in bone loss occurs during the process, rather than years down the line. And this is just at the time when a lot of women including their physicians are preoccupied with treating the symptoms of perimenopause in the moment rather than considering bone density.
Bone density is low causing osteoporosis and osteoporosis is a significant risk factor of fracture. The outcomes of hip fractures are particularly noteworthy: it is linked to decreased mobility, loss of independence, and meaningful higher rates of mortality in old women during the first postfracture year of life.
The bright side is that the loss in bone density is not invisible. Measurable by a DEXA scan (dual-energy X-ray absorptiometry), which is a non-invasive test complicated. DEXA scanning is advised in Australia in women aged over 50 years with other risk factors, and in all women aged 65 and above. The risk factors that accelerate the screening requirement comprise a family history of osteoporosis, smoking, low body weight, experience of fractures in adulthood, chronic use of corticosteroids and some medical conditions.
A recent finding that is not as obviously discussed but has evolved in increased importance over time is that bone health is closely related to the mass of muscles. Oestrogen helps to preserve muscle and as it declines it helps to bring on a slow loss of muscle mass and strength which is accelerated at menopause. It is called sarcopenia, and enhances the risk of fracture further; muscles with less strength imply deteriorated balance and an increased risk of falls, and that is how the majority of the fractures associated with osteoporosis actually occur.
This is among the main causes why resistance training, which involves weight management through exercise that builds and sustains muscle, is not merely a matter of weight management in the postmenopausal period. It is truly protective against bone density, falls, and fracture.
Two best nutrients that are most directly pertinent in the aftermath of menopause to bone health are calcium and vitamin D. Good calcium level helps in the body building blocks; vitamin D is needed to release calcium successfully through the gut. Uncommon vitamin D deficiency is prevalent in Australia, especially in women who spend minimal time in the open air or in those who dwell in southern areas in winter.
Calcium is found in the forms of dairy products, fortified plant milks, green vegetables that are leafy, tinned fish that has bones, and almonds. Women that cannot obtain the required calcium by means of food only, may consider the issue of supplementation with their physician.
The relationship between the brain and menopause is the youngest of the three that are scientifically comprehended, and, perhaps, the most interesting. It is also the one that elicits the fear of women, more so on the issue of dementia.
The oestrogen is not just flowing in the reproductive system. It operates within the brain. Oestrogen receptors appear all over the brain among others; there are hippocampus (most important in forming the memory), prefrontal cortex (or executive functions and planning operations), and the amygdala (heart of emotional reactions). Oestrogen also has an effect on the production of neurotransmitters such as serotonin, dopamine and acetylcholine that are all involved in mood, motivation and cognition.
The difficulties in concentrating, word-finding difficulties, and mental fogginess most women experience in perimenopause is not a myth and it is not merely as a result of poor sleep but sleep disruption certainly exacerbates it. They mirror actual shifts in the functioning of the brain during hormonal turbulence of the transition.
The most recent neuroimaging study, published in 2021 in Scientific Reports, scanned the brains of pre-menopausal, perimenopausal, and the postmenopausal women and identified significant differences in the brains of the three groups in terms of brain structure, connectivity, and energy metabolism. The alterations were conditional on menopausal endocrine ageing, but not chronological ageing, which is of vital importance that proves these changes by contrasting the results with age-matched men.
Importantly, the researchers also noticed that much of the structural brain differences they had seen in the transition mostly stabilised once the menopause had passed and grey matter volume returning in a cut of the most vital masses. This helps validate the opinion, as reported by the SWAN research, that menopause-associated cognitive alterations are mostly short-lived and do not mark the onset of an unavoidable cognitive impairment.
It is here that most of the anxiety of women is focussed and it is worth clarifying out. Women are also overrepresented in the Alzheimer disease cases. About two out of three individuals with Alzheimer oncology are women. This gap used to be explained by the mere reason women outlive men. However, more recent studies indicate that the explanation is more related to the biological complexities than that.
It has been shown that oestrogen plays neuroprotective roles, such as the inhibition of amyloid-beta, which is the protein making Alzheimer disease and its pathology. The neuroimaging study published in 2021 identified above established a greater amyloid-beta deposition in perimenopausal and postmenopausal women with an APOE-4 gene variant, the dominant genetic risk factor of late-onset Alzheimer disease, as opposed to men of the same genetic variant.
This is not to say that menopause is the cause of Alzheimer. It is more complex than it is manifested: There are genetic predispositions, lifestyles, heart health, and the timings and nature of the hormonal shift, all of which seem to be interacting the research is still trying to unravel. Nevertheless, it does indicate that the menopause transition might be an opportunity worth considering biologically that is worth considering rather than ignore.
Another thing to consider is that the changes of mood caused by the perimenopause, the anxiety, the irritability and the low mood are not mere psychological reaction towards the inconvenience of the symptoms. They are greatly neurological based and are on the direct effect of oestrogen on serotonin systems and GABA systems.
Oestrogen helps to regulate the serotonin amount found in the brain. Oestrogen swings during perimenopause cause a disruptive effect on serotonin signalling that may cause anxiety and mood disturbance even in women with no previous history of mental health issues. This is how the treatment of perimenopausal mood changes with the focus strictly on the psychological dimension without the inclusion of the hormonal motivator can lead to the development of management strategies that consider only one side of the coin.
Among recent menopause research findings, one of the most valuable ones was that cardiovascular health, bone health, and brain health are not silos. They relate to one another in significant manners, and that inherent hormonal change, oestrogen fall, is predisposing risk in all three.
Take an example of cardiovascular health and dementia: high blood pressure, elevated cholesterol, and vascular impairments during the middle of life are all known to be contributing factors to cognitive impairments and dementia later in the life. Therefore, the cardiovascular processes initiated by menopause are not only heart complications. They also are the indirectly caused brain health problems. Preventing cardiovascular postmenopause risk is, partially, an investment in cognition several decades later.
Likewise, all three systems are affected by low muscle mass and inappropriate physical fitness which are both caused by oestrogen reduction. Exercise preserves bone mass, aids in cardiovascular health, enhances insulin sensitivity, and is among the most evidence-based interventions to conserve cognitive functioning with age.
Although this is not a treatment guide, what the evidence at the lifestyle level continues to demonstrate is prevention of heart, bone, and brain health during the entire life of postmenopausal years.
The only intervention that is documented to have a wide range of benefit among the three systems is exercise. The evidence supports:
The Australian guidelines suggest a minimum of 150 minutes of medium intensity aerobic activity in one week, and two sittings of muscle-strengthening activities. In bone health especially, weight-bearing exercise is the most useful since it places mechanical stress on the bones.
The dietary needs of post menopausal women focus on several aspects:
Smoking increases almost all the health risks of menopause. It is linked to an earlier onset of menopause, faster bone loss, increased cardiovascular risk and poorer cognitive performance. It is also among the strongest modifiable risk factors of all three systems mentioned in the case of this post.
The postmenopausal period is a time which should be subjected to a systematic method of health care observations. Key checks include:
Cardiovascular Risk Assessment: An official evaluation that considers blood pressure, cholesterol, and smoking status, weight, family history, and so on to predict the risk of heart disease in general.
Menopause is a much more dramatic shift at the physiological level, than the hot flushes and mood swings that have become the conventional discourse on menopause. Its consequences on the heart, bones, and brain exist, are real and measurable, and have a long-lasting impact. They are also to a significant extent alterable via the options taken during and after the transition.
The greatest value that a woman can view in this communicated information is not the fear of possessing an understanding of what even occurs to her but just a clearer recognition of why the postmenopausal years need proactive care, as opposed to observant care. Being informed that your risk to the heart is increasing will provide you with the facts to yourself to manage it. It is something to consider as you know that bone loss is faster in transition and therefore you have a name to lose more bone health the sooner you think of it. The cognitive changes of perimenopause become much less frightening when one realizes that the brain is in the process of its own adjustment, and that much of that adjustment will resolve itself with time.
It is not something to be afraid of in learning about your body in this transition. It is all about being prepared to make good decisions in the decades to come by.